SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-241926
Filing Date
2020-09-09
Accepted
2020-09-09 11:20:35
Documents
12
Period of Report
2020-09-09
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d219013d8k.htm   iXBRL 8-K 25589
  Complete submission text file 0001193125-20-241926.txt   144441

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20200909.xsd EX-101.SCH 3056
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20200909_lab.xml EX-101.LAB 17372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20200909_pre.xml EX-101.PRE 10943
5 EXTRACTED XBRL INSTANCE DOCUMENT d219013d8k_htm.xml XML 3277
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 201165891
SIC: 2834 Pharmaceutical Preparations